| RS2544621386 |
PKD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Polycystic kidney disease, adult type |
| RS2544624546 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS2544624559 |
PKD1
|
Health Risk |
Pathogenic |
— |
| RS2544624572 |
SLC13A5
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 25 |
| RS2544624823 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS2544625256 |
PKD1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2544625519 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS2544625593 |
PKD1
|
Health Risk |
Pathogenic |
PKD1-related disorder, PKD1-related disorder |
| RS2544627057 |
TUBB3
|
Health Risk |
Likely pathogenic |
Complex cortical dysplasia with other brain malformations 1, Complex cortical dysplasia with other brain malformations 1 |
| RS2544627335 |
CNGB1
|
Health Risk |
Likely pathogenic |
— |
| RS2544627585 |
TUBB3
|
Health Risk |
Pathogenic |
— |
| RS2544627741 |
TUBB3
|
Health Risk |
Likely pathogenic |
See cases, Complex cortical dysplasia with other brain malformations 1 |
| RS2544627752 |
TUBB3
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS2544628814 |
CNGB1
|
Health Risk |
Pathogenic |
— |
| RS2544630752 |
CNGB1
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2544630794 |
CNGB1
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2544631133 |
PKD1
|
Health Risk |
Likely pathogenic |
Polycystic kidney disease, adult type |
| RS2544631346 |
PKD1
|
Health Risk |
Likely pathogenic |
Polycystic kidney disease, adult type |
| RS2544631623 |
PKD1
|
Health Risk |
Pathogenic |
PKD1-related disorder, PKD1-related disorder |
| RS2544633415 |
-
|
Health Risk |
Pathogenic |
Complex cortical dysplasia with other brain malformations 1, Complex cortical dysplasia with other brain malformations 1 |
| RS2544633545 |
CNGB1
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2544633550 |
CNGB1
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 45, Retinitis pigmentosa 45 |
| RS2544634307 |
SLC13A5
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 25 |
| RS2544635088 |
CNGB1
|
Health Risk |
Pathogenic |
— |
| RS2544636557 |
CNGB1
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 45, Retinitis pigmentosa 45 |
| RS2544637927 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS2544638357 |
SLC13A5
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 25 |
| RS2544638751 |
SLC13A5
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 25 |
| RS2544638776 |
RPGRIP1L
|
Health Risk |
Pathogenic |
Meckel-Gruber syndrome, Joubert syndrome |
| RS2544639462 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS2544639686 |
DNAH9
|
Health Risk |
Pathogenic |
— |
| RS2544640636 |
RPGRIP1L
|
Health Risk |
Pathogenic |
Joubert syndrome, Meckel-Gruber syndrome |
| RS2544640834 |
RPGRIP1L
|
Health Risk |
Likely pathogenic |
Joubert syndrome and related disorders, Joubert syndrome and related disorders |
| RS2544640942 |
RPGRIP1L
|
Health Risk |
Pathogenic |
Joubert syndrome, Meckel-Gruber syndrome |
| RS2544641047 |
SLC13A5
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 25 |
| RS2544646197 |
PKD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Polycystic kidney disease, adult type |
| RS2544646304 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS2544646598 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS2544646762 |
PKD1
|
Health Risk |
Pathogenic |
PKD1-related disorder, Polycystic kidney disease |
| RS2544646806 |
PKD1
|
Health Risk |
Pathogenic |
— |
| RS2544646868 |
PKD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Polycystic kidney disease, adult type |
| RS2544648459 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS2544648514 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS2544648778 |
PKD1
|
Health Risk |
Likely pathogenic |
Polycystic kidney disease, adult type |
| RS2544650057 |
PKD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Polycystic kidney disease, adult type |
| RS2544651188 |
CCDC88C
|
Health Risk |
Likely pathogenic |
— |
| RS2544651236 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS2544652543 |
PKD1
|
Health Risk |
Pathogenic |
PKD1-related disorder, Polycystic kidney disease |
| RS2544653894 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS2544654195 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS2544654552 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS2544655027 |
CNGB1
|
Health Risk |
Pathogenic |
— |
| RS2544655192 |
CCDC88C
|
Health Risk |
Pathogenic |
— |
| RS2544657206 |
DNAH9
|
Health Risk |
Pathogenic |
— |
| RS2544658236 |
RPGRIP1L
|
Health Risk |
Pathogenic |
Joubert syndrome, Meckel-Gruber syndrome |
| RS2544658938 |
FBXO7
|
Health Risk |
Likely pathogenic |
Parkinsonian-pyramidal syndrome, Parkinsonian-pyramidal syndrome |
| RS2544659214 |
FBXO7
|
Health Risk |
Pathogenic |
Parkinsonian-pyramidal syndrome, Parkinsonian-pyramidal syndrome |
| RS2544659247 |
FBXO7
|
Health Risk |
Pathogenic |
Parkinsonian-pyramidal syndrome, Parkinsonian-pyramidal syndrome |
| RS2544660833 |
SLC13A5
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 25 |
| RS2544661194 |
SLC13A5
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 25 |
| RS2544663258 |
BCAS3
|
Health Risk |
Likely pathogenic |
Hengel-Maroofian-Schols syndrome, Hengel-Maroofian-Schols syndrome |
| RS2544665272 |
FBXO7
|
Health Risk |
Pathogenic/Likely pathogenic |
Parkinsonian-pyramidal syndrome, Parkinsonian-pyramidal syndrome |
| RS2544671633 |
FBXO7
|
Health Risk |
Likely pathogenic |
Parkinsonian-pyramidal syndrome, Parkinsonian-pyramidal syndrome |
| RS2544672059 |
FBXO7
|
Health Risk |
Pathogenic |
Parkinsonian-pyramidal syndrome, Parkinsonian-pyramidal syndrome |
| RS2544674147 |
CNGB1
|
Health Risk |
Pathogenic |
— |
| RS2544676588 |
CNGB1
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2544678151 |
CNGB1
|
Health Risk |
Pathogenic |
— |
| RS2544678258 |
CNGB1
|
Health Risk |
Likely pathogenic |
— |
| RS2544680807 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2544680852 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS2544680914 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2544680951 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2544681110 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2544681155 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2544681214 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2544681269 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2544681358 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2544681392 |
NF1
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Hereditary cancer-predisposing syndrome |
| RS2544681396 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Juvenile myelomonocytic leukemia, Neurofibromatosis |
| RS2544681466 |
NF1
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Hereditary cancer-predisposing syndrome |
| RS2544681496 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2544681553 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2544681570 |
NF1
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Hereditary cancer-predisposing syndrome |
| RS2544681730 |
NF1
|
Health Risk |
Likely pathogenic |
— |
| RS2544681743 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2544681815 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2544681845 |
NF1
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 1 |
| RS2544681918 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2544683005 |
CNGB1
|
Health Risk |
Pathogenic |
— |
| RS2544685880 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS2544688079 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS2544688140 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS2544688348 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS2544688790 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS2544689115 |
PKD1
|
Health Risk |
Likely pathogenic |
— |
| RS2544690255 |
NF1
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Cardiovascular phenotype |
| RS2544690403 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2544690445 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2544690455 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2544690503 |
NF1
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Hereditary cancer-predisposing syndrome |